Eszopiclone: Difference between revisions
| [pending revision] | [pending revision] |
MDElliottMD (talk | contribs) Comprehensive categorization: +GABAA Positive Allosteric Modulators (General), GABAergics |
MDElliottMD (talk | contribs) Tier 2 taxonomy consolidation: remove retired Category:Anxiolytics & Sedative-Hypnotics |
||
| Line 32: | Line 32: | ||
[[Category:Z-Drugs (Non-Benzodiazepine Hypnotics)]] | [[Category:Z-Drugs (Non-Benzodiazepine Hypnotics)]] | ||
[[Category:Sedative-Hypnotics]] | [[Category:Sedative-Hypnotics]] | ||
[[Category:GABAA Positive Allosteric Modulators (General)]] | [[Category:GABAA Positive Allosteric Modulators (General)]] | ||
[[Category:GABAergics]] | [[Category:GABAergics]] | ||
Revision as of 17:44, 21 May 2026
Z-drug, Sedative-Hypnotic
Eszopiclone
Lunesta
Experience
No personal reports yet
No clinical reports yet
Log in to add your own experience.
Problems
No problems yet. Be the first to suggest one.
+ Add a problemTitration strategies
No titration strategies yet. Be the first to suggest one.
Effects
No effects listed yet. Be the first to suggest one.
Interactions
No interactions reported yet.
Relevant anecdote
No anecdotes yet. Share a relevant one.
Relevant Literature
No literature entries yet.
Log in to submit relevant literature.
Summary
Classes
Z-drug, Sedative-Hypnotic
Common uses
Pharmacy
Pharmacology
Purported mechanism
GABAA positive allosteric modulator (non-benzodiazepine)